Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ..

Burkitt lymphoma (BL) is a rare, mature, fast-growing and highly aggressive B-cell neoplasm. It has a high-proliferation rate with distinctive genetic changes in the C-MYC oncogene. Treatment usually requires intense and frequent chemotherapy regimens with central nervous system prophylaxis as the usual regimens used for other non-Hodgkin's lymphoma yield poor survival in BL. This report discusses a patient who was diagnosed with a stage II, high-grade BL who received one cycle of intense chemotherapy and refused further treatment. That patient remained in complete remission in his last follow-up; 7 years from diagnosis without requiring other therapies for his lymphoma.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

BMJ case reports - 14(2021), 4 vom: 20. Apr.

Sprache:

Englisch

Beteiligte Personen:

Al Sbihi, Ali [VerfasserIn]
Manasrah, Nouraldeen [VerfasserIn]
Sano, Dahlia [VerfasserIn]
Lonardo, Sarah [VerfasserIn]

Links:

Volltext

Themen:

Cancer intervention
Case Reports
Haematology (incl blood transfusion)
Head and neck cancer
Journal Article
Oncology

Anmerkungen:

Date Completed 14.05.2021

Date Revised 31.10.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1136/bcr-2020-240925

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM324338511